Clinical trials
Autoimmune Diseases trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Human Genome Sciences Inc., a GSK Company | 4 |
| University of Sao Paulo | 4 |
| Anthera Pharmaceuticals | 3 |
| GlaxoSmithKline | 3 |
| Bristol-Myers Squibb | 2 |
| Immunovant Sciences GmbH | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Viatris Innovation GmbH | 2 |
| Baxalta now part of Shire | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 32 |
| Lupus Erythematosus, Systemic | 18 |
| Connective Tissue Diseases | 8 |
| Immune System Diseases | 8 |
| Arthritis, Rheumatoid | 3 |
| Lupus Nephritis | 3 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 3 |
| Rheumatic Diseases | 3 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 1 | 2 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.